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 Obsessive Compulsive Disorder is a disabling condition, often associated with early onset and 
chronic course (Dell’Osso et al., 2013). Patients with OCD can also exhibit high degrees of 
comorbidity with other psychiatric disorders and increased suicidality (Dell’Osso et al., 2017; 
Lochner et al., 2014). A recent International multicenter investigation confirmed OCD patients 
can show first symptoms before adult age, with the majority of them showing childhood or 
adolescent onset (Dell’Osso et al., 2016). Early onset combined to the secretiveness that 
frequently characterizes the condition, as well as patient’s beliefs that OC symptoms do not 
represent a medical condition and that OCD can remit spontaneously, are all factors 
contributing to delayed diagnosis and first treatment, particularly of pharmacological nature 
(Benatti et al., 2016; Dell’Osso & Altamura, 2010; Poyraz et al., 2015). 
Given that age at onset and age of first pharmacological treatment concur to define the 
duration of untreated illness – practically computed by subtracting age at onset of a specific 
disorder from age of first pharmacological treatment and defined as the period of time 
elapsing from the onset of the disorder and the initiation of the first pharmacological 
treatment in therapy adherent patients, according to guidelines recommendations (Dell’Osso 
et al., 2013) , it is not surprising, based on the above, to observe that patients with OCD 
remain pharmacologically untreated for many years. Actually, published studies in the field 
showed that DUI in OCD can range from 3 to 8 years (Altamura et al., 2010; Bernardo 
Dell’Osso et al., 2013; Poyraz et al., 2015; Viswanath et al., 2011), with relevant consequences 
in terms of outcome and costs for affected patients, caregivers and society. While a uniform 
consensus on how to categorically differentiate short vs long DUI in OCD is lacking, with some 
studies using a threshold of 2 years and others of 4 years (Albert et al., n.d.; Poyraz et al., 
2015; Vigne et al., 2018) it is noteworthy to highlight that DUI in OCD patients was found to 
account for at least half of the overall duration of illness (DI) in studies assessing both 
variables. Over the last years, in fact, at least 5 independent studies conducted in different 
countries demonstrated that the largest part of the DI in OCD patients was represented by the 
DUI (see Table 1), meaning that assessed patients had spent the majority of their illness 
without receiving any pharmacological treatment.  
A first Indian study comparing patients with familial vs sporadic OCD in an overall sample of 
164 individuals, reported DUI values of 61.3 and 34 months, respectively, along with DI values 
of  95 and 69.3 months (Viswanath et al., 2011). 
Subsequently, an Italian study conducted by our group on a sample of 114 patients with OCD, 
aimed at exploring clinical differences across different phenotypes, found respectively a mean 
DUI of 87.3 months and a mean DI of 172.2 months for the whole sample (Dell’Osso et al., 
2014). The sample was subsequently enlarged to 124 patients divided in two groups on the 
basis of the severity of illness, indicating DUI and DI values of respectively 87.5 and 194.7 
months (Dell’Osso et al., 2017). 
In the same year, a Turkish study exploring differences between patients with a DUI below 
and above 4 years in an overall sample of 96 patients, reported values of DUI and DI of 7 and 
12.7 years, respectively (Poyraz et al., 2015). 
More recently, a Brazilian study exploring differences in patients with OCD, panic disorder 
and social anxiety disorder, found a DUI of 7.7 years and a DI of 19.3 years in the subsample of 
30 patients suffering from OCD (Vigne et al., 2018). 
Finally, a recently published Italian report on 251 patients with OCD, exploring treatment 
response on the basis of long vs short DUI, found a DUI of 106.2 months and a DI of 183.9 
months (Albert et al., in press). 
All reviewed reports, in spite of being conducted from independent groups on different 
samples in distinct countries, clearly converge in delineating a DUI of several years (around 7 
years in the majority of them), which represented, on average, a portion ranging between the 
40 and the 70% of the overall DI (see Figure 1). While it may be contended that: 1) current 
age of assessed samples was a major factor determining current duration of illness, implying 
that a higher DI/DUI ratio was easier to find in young-adult to mid-adult samples (compared 
to senior patients with a much longer DI), 2) that fluctuant versus chronic course is supposed 
to determine a different DI, and 3) that pharmacological treatment does not represent the 
only guideline-recommended intervention to treat OCD patients, we still contend that mean 
current age in the above-mentioned studies ranged from 30 to 40 years, with age at onset 
around 20 years, on average, which undoubtedly represent a crucial period for patients in 
terms of familial and work functioning.  
If, on one hand, some preliminary investigation, including patients with OCD, has recently 
shown that DUI can also depend on the epoch of onset, with patients with more distant onset 
having longer DUI compared to individuals with more recent onset (Dell’Osso et al., 2016),  
recent morphometric imaging investigation with the largest sample of adult and pediatric 
OCD patients assessed to date revealed that patients compared to controls had lower cortical 
thickness (Boedhoe et al., 2018). This finding, along with well-established alterations 
documented at the level of cortico-striato-thalamo-cortical circuits in OCD, allows to 
hypothesize that OCD, particularly when not effectively treated, can progress and entail 
cerebral alterations of either structural and functional nature, along with other negative 
clinical and psychosocial outcomes.    
Based on available literature in the field of DUI revealing that adult OCD patients had spent 
more than half of their illness pharmacologically untreated, we believe  that mental health 
professionals and policy makers should focus their effort on conducting and encouraging 
further investigation on the epidemiologic and clinical correlates of DUI in OCD, in order to 
promote early diagnosis and intervention programs for affected patients (Fineberg et al., 
submitted). 
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Table 1. Summary of the main features of the selcted manuscripts. 
 N Mean DUI Mean DI 
 
Viswanath et al., 2011 
84 
 
61.3 months/ 
familial OCD 
95 months/ 
familial OCD 
 
80 
34 months/ 
sporadic OCD 
69.3 months/ 
sporadic OCD 
Dell’Osso et al., 2014 114 87.3 months 172.2 months 
Poyraz et al., 2015 96 84 months 152.4 months 
Vigne et al., 2018 30 92.4 months 231.6 months 
Albert et al, in press 251 106.2 months 183.9 months 
Legend: DUI: duration of untreated illness; DI: duration of illness 
 
Figure 1. Mean DUI and DI reported in the selected manuscripts. 
 
Legend: DUI: duration of untreated illness; DI: duration of illness 
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